CanadaAPO-BRIMONIDINE-TIMOP eye drop solution (Apotex Inc.; DIN 02375311; brimonidine tartrate 0.2% w/v and timolol 0.5% w/v; Lot VK2312) may be affected. It was recalled because the weight is out of specification in the affected lot; verify whether your product is Lot VK2312, consult your healthcare provider before discontinuing use or for health concerns, contact Apotex with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Retailers
Companies: Apotex Inc., 380 Elgin Mills Road East,, Richmond Hill, ON, L4C 5H2,, Canada.
How to identify it
Brand: APO-BRIMONIDINE-TIMOP; Product Name: APO-BRIMONIDINE-TIMOP; Market Authorization: DIN 02375311; Dosage Form: Solution; Strength: Brimonidine tartrate 0.2% w/v and timolol 0.5% w/v (as timolol maleate); Lot: VK2312
The hazard
The weight is out of specification in the affected lot.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)